Loss of stearoyl-CoA desaturase 1 inhibits fatty acid oxidation and increases glucose utilization in the heart
Open Access
- 1 February 2008
- journal article
- Published by American Physiological Society in American Journal of Physiology-Endocrinology and Metabolism
- Vol. 294 (2), E357-E364
- https://doi.org/10.1152/ajpendo.00471.2007
Abstract
Stearoyl-CoA desaturase (SCD) is a lipogenic enzyme that catalyzes the synthesis of monounsaturated fatty acids (FA). SCD1 deficiency activates metabolic pathways that promote FA β-oxidation and decrease lipogenesis in liver. In the present study, we show that FA transport and oxidation are decreased, whereas glucose uptake and oxidation are increased in the heart of SCD1−/−mice. Protein levels of FA transport proteins such as FA translocase/CD36 and FA transport protein as well as activity of carnitine palmitoyltransferase 1, the rate-limiting enzyme for mitochondrial fat oxidation, were significantly lower in the heart of SCD1−/−mice compared with SCD1+/+mice. Consequently, the rate of palmitoyl-CoA oxidation was decreased significantly in the heart of SCD1−/−mice. mRNA levels of peroxisome proliferator-activated receptor-α, a key transcription factor controlling genes of FA oxidation, were significantly reduced in SCD1−/−mice. Phosphorylation of insulin receptor substrate-1 (IRS-1) and the association of αp85 subunit of phosphatidylinositol 3-kinase with IRS-1 were significantly higher under both basal and insulin-stimulated conditions in SCD1−/−hearts. This increased insulin sensitivity translated to a 1.8-fold greater 2-deoxyglucose uptake and 2-fold higher rate of glucose oxidation in the myocardium compared with SCD1+/+counterparts. The results suggest that SCD1 deficiency causes a shift in cardiac substrate utilization from FA to glucose by upregulating insulin signaling, decreasing FA availability, and reducing expression of FA oxidation genes in the heart. This increase in cardiac insulin sensitivity and glucose utilization due to SCD1 deficiency could prove therapeutic in pathological conditions such as obesity that are characterized by skewed cardiac substrate utilization.Keywords
This publication has 41 references indexed in Scilit:
- Fatty acid metabolism is enhanced in type 2 diabetic heartsBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2005
- Stearoyl-CoA desaturase-1 deficiency reduces ceramide synthesis by downregulating serine palmitoyltransferase and increasing β-oxidation in skeletal muscleAmerican Journal of Physiology-Endocrinology and Metabolism, 2005
- Enhanced Sarcolemmal FAT/CD36 Content and Triacylglycerol Storage in Cardiac Myocytes From Obese Zucker RatsDiabetes, 2004
- Effects of Ranolazine With Atenolol, Amlodipine, or Diltiazem on Exercise Tolerance and Angina Frequency in Patients With Severe Chronic AnginaA Randomized Controlled TrialJAMA, 2004
- Physiological role of AMP-activated protein kinase in the heart: graded activation during exerciseAmerican Journal of Physiology-Endocrinology and Metabolism, 2003
- Role for Stearoyl-CoA Desaturase-1 in Leptin-Mediated Weight LossScience, 2002
- Malonyl-CoA metabolism in cardiac myocytes and its relevance to the control of fatty acid oxidationBiochemical Journal, 1993
- Paradoxical role of lipid metabolism in heart function and dysfunctionMolecular and Cellular Biochemistry, 1992
- The effect of fasting on the activity of liver carnitine palmitoyltransferase and its inhibition by malonyl-CoABiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1981
- A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATIONCanadian Journal of Biochemistry and Physiology, 1959